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ABSTRACT

Rakoczy, Ryan J. M.S., Department of Neuroscience, Cell Biology, and Physiology,
Wright State University, 2017. Measuring the Effects of High-Fat Diet on Respiration
and Oxygen-Sensitivity of the Carotid Body Type I Cell.
The carotid bodies (CB), the primary peripheral chemoreceptors, respond to changes in
blood gases with neurotransmitter release, thereby increasing carotid sinus nerve firing
frequency and ultimately correcting the pattern of breathing. It has previously been
demonstrated that acute application of the adipokine leptin caused perturbations of
intracellular calcium and membrane ion movement in isolated CB Type I cells (Pye et al,
2015) and augmented the response of the intact CB to hypoxia (Pye et al, 2016). This
study’s aim was to examine, in-vivo, if elevated leptin modulated CB function and
breathing.
Rats were fed high-fat chow or control chow for 16-weeks. High-fat fed (HFF) animals
gained significantly more weight compared to control fed (CF) animals (n=18; p<.001;
512.56 g ± 14.70 g vs. 444.11 g ± 7.09 g). HFF animals also had significantly higher
serum leptin levels compared to CF (n=18; p<.0001; 3.05 ng/mL ± 0.24 ng/mL vs. 1.29
ng/mL ± 0.12 ng/mL). Whole-body plethysmography was used to test the acute hypoxic
ventilatory response (HVR) in unrestrained, conscious animals. HFF animals had an
attenuated 2nd-phase of the HVR when compared to CF (n=18; p<.05; 710.1 ± 41.9 mL
kg-1 min-1 vs. 855.4 ± 44.05 mL kg-1 min-1). CB Type I cells were isolated and
intracellular calcium measured; no significant differences in the cellular hypoxic
responses between groups were observed.
iii

These data show differences in the 2nd-phase of the HVR caused by high fat feeding are
unlikely to be caused by an action of leptin on the Type I cells. However the possibility
remains that leptin may have in-vivo postsynaptic effects on the carotid sinus nerve; this
remains to be investigated.
This work appeared in abstract and poster form at the Ohio Physiological Society
meeting 2016, Experimental Biology 2017, and the International Society for Arterial
Chemoreception (ISAC) meeting 2017.
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INTRODUCTION
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Obesity & Breathing:
The prevalence of obesity in the United States has steadily increased over the last
four decades (Flegal et al., 2016). Characterized by a high intake of salt, refined sugars,
saturated and omega-6 fatty acids, and a low intake of the cardio-protective fatty acid
omega-3, the deservedly coined “western diet” is mainly to blame for the continuation of
this rampant epidemic (Myles, 2014; Lee et al., 2008). Obesity brings with it a plethora
of comorbidities and physiological changes including insulin and glucose intolerances,
cardiovascular disease, liver disease, metabolic dysfunction, and hormone imbalances
(Bjorntorp, 1995; Castro et al., 2014). One physiological change of particular interest is
the development of “obesity hypoventilatory syndrome” (OHS), a phenomenon defined
by a marked decrease in respiration in obese individuals (Egea-Santaolalla & Javaheri,
2016; Berger et al., 2009). OHS is also characterized by respiratory muscle dysfunction,
impaired chemosensation (i.e., drive to breath), and arterial blood PCO2 levels ≥45
mmHg occurring in the absence of pulmonary pathologies (i.e., COPD) that would justify
the hypercapnia (Fox, 2014; Herer et al., 2003; Egea-Santaolalla & Javaheri, 2016).
Along with a multi-factorial hypothesis for development, evidence also points to
hormonal dysregulation leading to respiratory depression. For example, Phipps and
colleagues (2002) took blood samples of obese patients, quantified hormone levels, and
correlated them with blood gas levels. They found a significant and positive correlation
between serum leptin levels and PCO2 levels.
Leptin & Breathing:
Leptin, a hormone made and secreted by adipose cells, serves as a satiety and
energy-regulating hormone; exerting its central effects on neurons in the arcuate nucleus
2

of the hypothalamus, leptin serves to suppress appetite (Cowley et al., 2000). Much of the
research studying leptin’s physiological role has been performed in mice unable to
produce functional leptin, ob-/ob- mice (C57BL/6J-Lepob) (Coleman, 1978; O’Donnell et
al., 2000). Zhang and colleagues (1994) were the first to clone the mouse ‘ob’ gene and
its’ highly conserved, 167-amino-acid human homologue. In mice, a mutation in this
codon causes production of a non-functional leptin protein which leads to profound
obesity via hyperphagia (Zhang et al., 1994). Concurrently with weight-gain,
development of impaired respiratory mechanics and attenuated respiratory control is
noted in ob-/ob- mice (O’Donnel et al., 2000). However, in these animals, respiratory
depression is present before the onset of obesity, thus suggesting that an absence of leptin
can serve as a respiratory depressant. For example, infusion of exogenous leptin into ob/ob- mice serves as a respiratory stimulant causing a profound increase in minute
ventilation (O’Donnell et al., 1999; O’Donnell et al., 2000). This is an important finding
because extremely high circulating leptin levels can normally be found in the blood of
obese humans (Friedman & Halaas, 1998). However, despite hyperleptinemia in obese
humans, marked respiratory depression persists (Campo et al., 2007).
One explanation for the respiratory depression accompanied with hyperleptinemia
is leptin resistance or leptin insensitivity (O’Donnell et al., 2000; Manzella et al., 2002).
For example, Heek et al. (1997) observed that after receiving chronic, peripherally
infused, exogenous leptin over 56 days, mice began showing signs of resistance to
leptin’s appetite suppressing effects (e.g., hyperphagia). Recently, chronically elevated
leptin levels have been correlated with respiratory depression and an attenuated
hypercapnic response in humans (Campo et al., 2007; Phipps et al., 2002). Several
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mechanisms by which leptin effects respiration have been hypothesized. For example,
leptin is known to cross the blood brain barrier (BBB) and stimulate breathing via its
actions on central respiratory centers (e.g., nucleus tractus solitarius: NTS). Focal
injections of leptin into the NTS, a well-studied central respiratory center, caused dosedependent increases in minute ventilation in rats (Inyushkina et al., 2009; Inyushkina et
al., 2010). Hypoventilation in obese individuals may be due to leptin resistance at the
BBB caused by chronic saturation and subsequent downregulation of leptin transporters
(Banks et al., 1996). In addition to modulation of breathing centrally, leptin has recently
been shown to effect breathing via its actions on receptors on the peripheral
chemoreceptors, the carotid bodies (Porzionato et al., 2011; Pye et al., 2016; Pye et al.,
2015). For example, Pye and colleagues (2016) noted that acute administration of obese
levels of leptin (i.e., 200 ng/mL) to the intact and the isolated type I cells of the carotid
body caused dose-dependent rises in baseline firing rates. This evidence provides a
mechanism by which leptin can influence breathing via its actions in the periphery via the
carotid bodies.
Control of breathing via the Carotid Body:
The carotid bodies are bilaterally located at the bifurcation of the common carotid
artery and detect pH, PCO2, and PO2 changes in arterial blood (Peers, Wyatt, & Evans,
2010; Gonzalez et al., 1992). Through afferent carotid sinus nerve (CSN) inputs to the
brainstem (i.e., ventral medulla, nucleus tractus solitarius) via the glossopharyngeal nerve
(cranial nerve IX), the carotid bodies correct the pattern of breathing to regain blood gas
homeostasis in the arteries (Finley & Katz, 1992; Peers, Wyatt, & Evans, 2010).
Experiments conducted by Corneille Heymans (1930, 1965) are generally regarded as
4

being the first to experimentally describe the chemosensitive nature of the carotid bodies.
Utilizing a cross-circulation technique, the carotid arteries of one dog (dog A) were
connected to the carotid arteries of another (dog B). While dog A inspired a hypoxic gas,
notable increases in breathing movements (e.g., chest movement, nostril flaring, larynx
tightening) were observed in dog B. A schematic of this experiment is shown as a cartoon
drawing in Figure 1. Heymans’ work in the field was preceded by others, including
Fernando De Castro who is regarded as the first to describe the fine anatomical and
morphological characteristics of the carotid body. His early work differentiated the
innervation of the carotid body from that of the nearby carotid sinus, which serves
baroreceptors on the internal carotid artery (De Castro, 1926). De Castro (1928), through
denervation studies, gained further support for the hypothesis that the carotid bodies were
serving as chemosensors that sampled arterial blood on its way to the brain.
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Figure 1. Schematic of Corneille Heymans (1965) cross-circulatory experiment by which
perfusion of the carotid artery (supplied from dog A) was separate from dog B’s systemic
circulation. A hypoxic stimulus, provided to dog A, caused increases in breathing
movements in dog B due to activation of the chemosensitive carotid bodies.
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The carotid bodies have been demonstrated to sense acute changes in the blood
gas composition of the arterial blood supply. Although the exact mechanism by which the
carotid bodies sense oxygen is unknown, several possibilities have been hypothesized.
The type I (glomus) cells of the carotid body are regarded as the organ’s “basic
chemotransductive unit[s]” (Fitzgerald, 2000). These cells contain numerous
neurotransmitters (i.e., dopamine, norepinephrine, serotonin) and form synapses with
afferent carotid sinus nerve fibers which propagate signals to the NTS via the
glossopharyngeal nerve (Peers, Wyatt, & Evans, 2010; Fitzgerald, 2000; Nurse, 2005;
Gonzalez et al., 1994). Figure 2 provides a schematic of the fine and gross
morphological and anatomical features of the carotid body.
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Figure 2. A) Schematic from Peers, Wyatt, & Evans (2010) showing the gross
morphology and anatomical location of the carotid body at the bifurcation of the common
carotid artery (CC). The CC diverges into the internal carotid (IC) and external carotid
(EC); at the base of this bifurcation the carotid body is normally found. B) Schematic
showing the fine anatomical and morphological characteristics of the carotid body.
Chemosensitive type I cells contain neurotransmitters, synapse with afferent carotid sinus
nerve fibers, and are surrounded by supportive, glial-like type II cells. A dense capillary
network provides a rich arterial blood supply to the organ allowing it to detect minute
changes in blood gas composition.
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The exact mechanism by which the carotid bodies detect changes in the blood gas
composition of the arterial blood supply is hotly debated. Since Heyman’s discovery of
the chemosensitive nature of the carotid bodies in the early 1900’s, many mechanisms of
oxygen-sensing have been hypothesized. It has been demonstrated that hypoxia-induced
carotid body type I cell neurotransmitter release is dependent and graded upon the
severity of hypoxia (Buckler & Vaughan-Jones, 1994). Buckler & Vaughan-Jones (1994)
showed that in the absence of extracellular calcium, carotid body responses to hypoxia
were 98% inhibited. In the presence of an L-type calcium channel antagonist, nicardipine,
cellular hypoxic responses were inhibited by over two-thirds that of the control (Buckler
& Vaughan-Jones, 1994). These results from Buckler & Vaughan-Jones (1994) suggest
extracellular calcium is necessary for the cellular response to hypoxia. However, for
calcium influx to occur, membrane depolarization must precede this event. Several
groups have reported that hypoxia inhibits potassium channels in type I cells. LopezLopez (1989) performed whole-cell patch clamp electrophysiology on isolated type I
cells and noted, on average, a graded decrease in potassium channel currents when cells
were exposed to varying degrees of hypoxia (between 70 and 120 mmHg O2). Inhibition
of TASK-like background potassium-currents (i.e., TASK-1 & -3) have been
demonstrated to potentially underpin the mechanism by which type I cells respond to
hypoxia with cellular depolarization (Kim et al., 2009; Buckler, 2007; Buckler, Williams,
& Honore, 2000). When challenged with hypoxia, inhibition of these TASK-channels
leads to cellular depolarization, calcium influx, and neurotransmitter release; a schematic
of this event is shown in Figure 3. Inhibitors of oxidative phosphorylation are also
profound stimulants to the type I cells of the carotid body (Kim et al., 2009; Buckler,
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2007; Wyatt & Buckler, 2004). Wyatt and Buckler (2004) noted rapid rises in
intracellular calcium levels when mitochondrial inhibitors (i.e., cyanide, oligomycin)
were applied to isolated carotid body type I cells. Observed cellular responses, similar to
cellular hypoxic responses, provided Wyatt & Buckler (2004) evidence for the hypothesis
of oxygen-sensing via the carotid body type I cell mitochondria. Although there exists a
lack of general consensus about the exact oxygen-sensing mechanism of the carotid
bodies, a multi-faceted sensing mechanism hypothesis which involves interplay between
ligand-receptor binding, ion channels, and mitochondrial metabolism may more fully
explain the oxygen-sensing nature of the carotid body type I cells (Buckler & VaughanJones, 1994; Lopez-Barneo et al., 2016; Fitzgerald, 2000).
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Figure 3. A schematic showing the hypothesized chemosensory mechanism of
the carotid body type I cell. Briefly, a chemostimulus (i.e., hypoxia) causes the closing of
chemosensitive potassium channels (i.e., TASK-1, TASK-3). Subsequent membrane
depolarization opens voltage-gated calcium channels allowing a rise in intracellular
calcium followed by exocytosis of neurotransmitter filled vesicles.
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Effects of Diet on Breathing
It has been demonstrated in rats that high fat feeding induces obesity,
hyperleptinemia, and depresses breathing both at rest and during exposure to hypoxia
(Olea et al., 2014). When high fat fed, obese rats were chronically exposed to hypoxia,
such as experienced by humans suffering from sleep apnea, leptin levels were
significantly raised compared to obese controls (Olea et al., 2014). High fat fed animals
chronically exposed to hypoxia also demonstrated a significant blunting of their breathing
during hypoxic exposure compared to obese controls (Olea et al., 2014). Several
mechanisms have been put forth in an attempt to explain the breathing depression that
accompanies obesity, or as it is clinically termed, obesity hypoventilatory syndrome
(OHS). Increased abdominal and chest adipose tissue deposition is evident in obese
individuals and our HFF rats and restricts the expansion of the diaphragm during
inspiration and puts added stress on respiratory muscles increasing the likelihood of
fatigue (Al Dabal & BaHammam, 2009). Restriction of diaphragm movement reduces the
total lung capacity and tidal volume of affected individuals (Salome, King, & Berend,
2010). Lowered tidal volume decreases minute ventilation and gas exchange, thus
allowing the accumulation of CO2 within the blood, as is evident in individuals suffering
from OHS (Fox, 2014; Herer et al., 2003; Egea-Santaolalla & Javaheri, 2016).
Individuals suffering from OHS, despite low PO2 and high PCO2, show signs of
diminished chemosensation. For example, in a healthy human, low PO2 and high PCO2
would serve as strong respiratory stimulants to the carotid bodies or central respiratory
centers (i.e., NTS) (Wyatt et al., 1995; Conrad et al., 2009). Despite chronic hypercapnia
and hypoxia, individuals suffering from OHS still demonstrate remarkably depressed
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breathing. This evidence suggests a potential attenuation of the chemosensory responses
of the carotid bodies.
Carotid Body & Leptin
It has recently been demonstrated that functional leptin receptors, both long (ObRb) and short isoforms (Ob-Ra – Ob-Rf) exist on the type I cell of the rat and human
carotid body (Ob-Rf>Ob-Rc>Ob-Ra>Ob-Rb) (Porzionato et al., 2011). Pye and
colleagues (2015 & 2016) observed that obese quantities of exogenous leptin (i.e., 200
ng/mL) administered in acute doses to both isolated type I cells of the carotid body and
ex-vivo, intact, and arterially perfused carotid bodies, increased their baseline firing rates
and sensory responses to hypoxia. Depolarization of carotid body type I cells leads to NT
release and increased firing rates of the CSN, subsequently leading to increases in
breathing via inputs to the NTS within the brainstem. This experimental evidence
demonstrates leptin’s potential ability to modulate breathing in the periphery via its
actions on the carotid body (Porzionato et al., 2011; Pye et al., 2015; Pye et al., 2016).
It was the aim of the following study to build upon the work completed by Pye
and colleagues in 2015 and 2016. They investigated the effects leptin has on the isolated
type I cell of the carotid body. As stated previously, application of exogenous leptin, in
obese levels, increased the hypoxic sensory response of isolated and intact carotid body
type I cells (Pye et al., 2015; Pye et al., 2016). In the present study, we aimed to increase
circulating serum leptin levels, in-vivo, through a high-fat feeding paradigm. High fat
feeding has been demonstrated to lead to excessive weight gain and a subsequent rise in
serum leptin levels (Van Heek et al., 1997; Knight et al., 2010). It is hypothesized that
chronic overstimulation of leptin receptors (i.e., due to hyperleptinemia) on the carotid
13

bodies will cause their downregulation and/or insensitivity, potentially leading to a
blunting of the carotid body mediated hypoxic response. Utilizing whole-body
plethysmography to test breathing parameters, assessment of the acute hypoxic
ventilatory response (HVR) will be made. We hypothesize HFF animals will have
blunted hypoxic responses due to a decrease in the hypoxic sensory responses of the type
I cells of the carotid body. Resection of the carotid bodies, followed by type I cell
isolation and intracellular calcium measurements, will indicate whether the depression in
breathing that accompanies obesity is due to leptin’s actions on these oxygen-sensing
organs.

14

Methods
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Animals
36 adult male, Sprague-Dawley rats (≥250g; Envigo) were used for this study.
Animals were acquired in groups of six and housed doubly in polypropylene cages stored
on a steel cage rack in a rodent colony room. The room was kept at a constant
temperature (24◦ C) and humidity (50% RH), and lights on a 12-hour light-dark cycle.
Twice-weekly cage changes provided fresh Sani-Chip® bedding (7090 Teklad; Envigo)
to animals in sterilized polypropylene cages with stainless steel cage-tops. Animals were
provided ad libitum access to chow and reverse osmosis purified water.
Diet
Animals were assigned to either a control (n=18) or high-fat diet group (n=18) for
16-weeks (118 days ± 1). The high-fat chow (TD.06414; Harlan) was composed of the
following ingredients (grams of ingredients/kilogram of chow): casein, 265g; L-cystine
4g, maltodextrin, 160g; sucrose, 90g; lard, 310g; soybean oil, 30g; cellulose, 65.5g;
mineral mix “AIN-93G-MX #94046”, 48g; dibasic calcium phosphate, 3.4g; vitamin mix
“AIN-93-VX #94047”, 21g; choline bitartrate, 3.0g; blue food color, 0.1g.
Approximately 60% of total calories were provided via fat (approximately 37% saturated,
47% monounsaturated, and 16% polyunsaturated); energy density was approximately 5.1
Kcal/g. The control chow (TD.08806; Harlan) was ingredient-matched to the high-fat
chow and included (grams of ingredients per kilogram of chow): casein, 210g; L-cystine,
3g; corn starch, 465g; maltodextrin, 100g; sucrose, 90g; lard, 20g; soybean oil, 20g;
cellulose, 37.15g; mineral mix “AIN-93G-MX #94046”, 35g; dibasic calcium phosphate,
2g; vitamin mix “AIN-93-VX #94047”, 15g; choline bitartrate, 2.75g; yellow food color,
0.1g. Approximately 10% of total calories were provided via fat; energy density was
16

approximately 3.6 Kcal/g. Chow was stored at 4◦ C until provided to animals. Animals
were weighed (OHAUS CS2000; Parsippany, NJ) weekly to ensure proper weight gain.
Metabolism
Resting metabolism was studied using indirect calorimetry through measuring production
of CO2 and consumption of O2 by the animal during normal respiration (Ferrannini,
1988). A respiratory exchange ratio (RER) was calculated for each of 36 animals by
dividing VCO2 (mL of CO2 produced min-1 kg-1) by VO2 (mL of O2 produced min-1 kg-1),
after values were corrected to standard pressure, temperature, and the partial pressure of
water subtracted. Using a MOXUS Metabolic Cart (AEI Technologies), room air was
pulled through a ~4L sealed (except for air inlet and outlet holes), halcyon chamber
containing the unrestrained animal. Air passed through a flow sensor at 560mL
±20mL/min before passing through a CO2 sensor and then CO2 analyzer (CD-3A; AEI
Technologies). From the CO2 sensor, the air was dried with desiccant (DM-AR; Perma
Pure, LLC.) before being pulled through an O2 sensor and then passed to an O2 analyzer
(S-3A/I; AEI Technologies). Both the CO2 and O2 analyzers passed independent signals
to a transducer (MP150; BIOPAC Systems, Inc.) which relayed data to a computer
running acquisition software (AcqKnowledge; BIOPAC Systems, Inc.). Data was
compiled in Microsoft Excel and statistics ran in Graphpad Prism (v7.00). Animals were
allowed 30-minutes to acclimate to the chamber before 30-minutes of experimental
recordings. Figure 4 shows a schematic of the metabolic system setup.

17

Figure 4: Schematic showing experimental setup for measuring resting metabolism via
an indirect calorimetric method (measuring CO2 production and O2 consumption)
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Whole-Body Plethysmography
Whole-body plethysmography (WBP: FinePointe; Buxco/DSI) was utilized to
measure breathing parameters (i.e., frequency, tidal volume, minute ventilation) in
conscious, unrestrained animals after 16-weeks of high-fat or control chow feeding. A
schematic of this setup in shown in Figure 5. Briefly, animals were placed inside of a 4L
halcyon experimental chamber that had a constant flow (2.5 L/min) of humidified gas
(26◦C ±1◦C; 35%±10% relative humidity) to prevent the buildup of CO2 and depletion of
O2. Box-flow (mL/min) was measured via a differential pressure sensor recording from
both experimental and reference chambers; lung mechanic parameters were inferred from
the pressure changes produced by the animals breathing movements. A pre-calibrated
temperature and humidity probe continuously monitored and recorded changes in the
chamber environment. Pressure sensor calibration was achieved via direct injection of a
1mL bolus of air into the experimental chamber and was automated by computer
software. Pressure changes produced by inhalation and exhalation of the animal were
transduced into an electrical signal by the pressure sensor, amplified (QT Digital
Preamplifier; Buxco), and then digitally processed and stored via system software
(FinePointe v2.3.1.16; Buxco/DSI) as two-second averages. Acquisition software
automatically rejected sniffing: breaths with inspiratory time’s less than 60 milliseconds.
Animals were acclimated to the chamber for 30-minutes in normoxic conditions (21%
O2, balanced N2) before baseline recordings were made. Oxygen and nitrogen
concentrations were manipulated via a gas mixer (Pegas 4000 MF; Columbus
Instruments) to produce an acute hypoxic (10% O2, balanced N2) environment within the
chamber. A fiber-optic oxygen sensor (OxyMicro; WPI) was placed inside of the
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chamber to confirm proper chamber oxygen levels. Immediately after hypoxic exposure,
normoxic conditions were reestablished.
A single, five-minute hypoxic exposure (10% O2, balanced N2) tested the acute
hypoxic response of all 36 conscious, unrestrained rats fed either a high-fat or control
diet. After acclimation and baseline recordings, an initial 45-second output of 100%
nitrogen (~2 L of nitrogen) from the gas mixer created hypoxic conditions (10% O2) that
were then maintained for a total of five minutes via gas mixer output of 10% oxygen,
balanced nitrogen at 2.5 L/min. After five minutes, normoxia was reestablished (21% O2,
balanced N2). Data (i.e., tidal volume, frequency, minute ventilation) were averaged by
system software (FinePointe v2.3.1.16; Buxco/DSI), compiled in Microsoft Excel, and
statistics ran in Graphpad Prism (v7.00).
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Figure 5: Schematic showing whole-body plethysmography experimental setup.
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Carotid Body Type I Cell Isolation
Dissection: Two adult Sprague-Dawley rats were used for each day of experiments.
Animals were kept on a control or high-fat diet for 16 weeks before having carotid bodies
resected (anatomical location shown in detail in Figure 6). Each rat was placed singly in
an anesthesia chamber and exposed to 4.5% isoflurane at 0.9L min-1 until unconscious; a
foot pinch tested the animals’ withdrawal reflex to confirm proper stage of anesthesia
was achieved. Animals were then decapitated via guillotine (DCAP; WPI) just above the
clavicle bone and the decapitated head placed on a dissecting microscope (Omano, Japan)
stage. Neck skin was removed via an initial midline sagittal cut, parallel with the trachea,
using fine forceps (Dumont #5; Fine Science Tools) and dissection scissors (Noyes; Fine
Science Tools) exposing subcutaneous fascia. Salivary glands and associated lymph
nodes were separated and reflected to either side; remaining tissue (e.g., connective,
adipose) and skeletal muscles (e.g., sternohyoid, sternomastoid, omohyoid) were
removed to expose the bifurcation of the common carotid artery on each lateral side of
the trachea, one at a time, using fine forceps (Dumont #5; Fine Science Tools). The
hypoglossal nerve, located superior to the common carotid artery and classically used as
an anatomical landmark during dissection, was cut and reflected to further expose the
bifurcation of the common carotid artery. Once exposed, connective and adipose tissue
connected to the artery was carefully removed. Next, the occipital artery, connected to the
external carotid artery, was cut and reflected to expose the carotid body located on the
internal carotid artery near the bifurcation. Once located, the carotid body was carefully
removed using fine forceps (Dumont #5; Fine Science Tools) and placed in a 35mm petri
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dish (Fisherbrand) containing ice-chilled Dulbecco’s phosphate buffered solution (DPBS)
without calcium or magnesium (Sigma-Aldrich).
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Figure 6: Cartoon adapted from Peers et al. (2010) depicting the anatomical location of
the Carotid Body: found at the bifurcation of the common carotid artery (CC) where the
vessel separates into the internal (IC) and external carotid (EC) arteries. The Carotid
Body sits at the base of this bifurcation and is distinguished from surrounding tissue by
its pearl-like appearance in color and shape.
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Carotid Body Dissociation
Four carotid bodies, held in ice-chilled DPBS without calcium or magnesium (SigmaAldrich), had excess adipose and connective tissue removed before being transferred to a
new 35mm petri dish containing 2.5-3mL of a digestive enzyme cocktail (200mcg mL-1
Trypsin Type I (Sigma) & 400mcg mL-1 Collagenase Type I (Worthington) in DPBS with
low calcium and magnesium (Sigma-Aldrich)). Digestion of carotid body connective
tissue was accomplished via a 20 minute incubation at 37◦C in a cell culture incubator
(HeraCell 150i; Thermo Scientific); incubator air was humidified and held at 5% CO2,
balanced room air. Carotid body tissue, still in the digestive enzyme cocktail, was
mechanically separated using fine forceps before being incubated again for an additional
seven minutes. The tissue-containing enzyme solution was next moved to a 15mL PET
centrifuge tube (Fisherbrand) and centrifuged (GPR; Beckman) at 750RPM (130g) for
five minutes. Supernatant was removed leaving a pellet of tissue that was then resuspended and titrated in 2mL of Ham’s F-12 culture medium containing L-glutamine
and sodium bicarbonate (Sigma-Aldrich), enriched with 10% fetal bovine serum
(Biowest), used to halt enzymatic dissociation of the tissue. Another five minute
centrifugation at 750RPM (130g) reformed the tissue pellet allowing removal of
supernatant, leaving ≈80-100μL of culture medium containing the dissociated cells.
Using a Sigmacote (Sigma) internally-coated Pastuer pipette (VWR) with a fire polished
tip, the cell containing medium was triturated to further dissociate cells. Four 15mm glass
coverslips (Warner Instruments) previously coated with aqueous poly-d-lysine
(0.1mg/mL; Sigma Aldrich) had one 20-25μL drop of cell containing media placed on
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their surface. Coverslips were incubated for two hours to promote cell adherence before
being used for experimentation within eight hours.

Blood Collection
Animals were anesthetized before being euthanized via guillotine-assisted
decapitation as described above. Immediately after decapitation, the animal’s body was
held by its tail over a Pyrex glass funnel and whole-blood drained from the neck into four
1.5mL non-additive polypropylene micro-centrifuge tubes (Fisher Scientific). Blood was
allowed to clot (to avoid hemolysis) at room temperature for 20 minutes before an initial
20-minute centrifugation (Mini Spin Plus; Eppendorf) at 14,000RPM (13148g).
Separated serum was removed and placed into a 1.5mL micro-centrifuge tube and
subjected to another centrifugation for six minutes at 14,000RPM (13148g). Serum was
removed and aliquoted into two 0.5mL non-additive polypropylene micro-centrifuge
tubes (Safe-Lock Tubes; Eppendorf) and frozen at -15◦C until used.
Lung and Heart Resection
Animals were anesthetized before being euthanized via guillotine-assisted
decapitation, as described previously, after which the heart and lungs were dissected and
weighed (Frappell & Mortola, 1994). The carcass was placed on a dissection table and,
using dissection scissors (Noyes; Fine Science Tools), an initial sagittal cut through the
chest wall exposed the heart in the thoracic cavity. The superior vena cava, inferior vena
cava, aorta, and pulmonary arteries and veins were removed by cutting them at the base
of the atrium (e.g., superior vena cava) or ventricle (e.g., pulmonary artery), depending
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on the vessel. Once vessels were detached, the heart was removed from the animal, blood
drained, and non-cardiac connective and adipose tissue removed from the outer lining of
the heart. The lungs were resected next via cutting of the trachea in line with the apex of
the left and right superior lobes. The lungs were removed from the thoracic cavity and
connective and adipose tissue removed from the outer surface of the lungs. An immediate
“wet” weight of each organ was taken (APX-153; Denver Instrument) followed by a
“dry” weight, taken (APX-153; Denver Instrument) after the organ was dried in an oven
(Isotemp Oven 215G; Fisher) at 75◦C for 24 hours (Frappell & Mortola, 1994). “Dry” and
“wet” organ weights were averaged and these values used for analyses.
Leptin Enzyme Linked Immunosorbent Assay
Serum leptin concentrations were quantified using an ELISA (KRC2281; Novex) with
monoclonal antibodies following manufacturers protocol. Briefly, non-fasted animals
were anesthetized, euthanized, and blood processed as previously described. Frozen
serum samples were thawed at room temperature, aliquoted, and diluted to 5-fold and 20fold their original concentrations using a Standard Diluent Buffer (Novex). Each sample
dilution was tested doubly in separate wells on a 96-well ELISA plate (Novex) – equating
to four tests per sample. A rat Leptin Standard (Novex) was reconstituted using a
Standard Diluent Buffer to produce standard concentrations (pg/mL): 4000, 2000, 1000,
500, 250, 125, 62.5, and 0; standards were placed doubly in single wells on the same
plate containing serum samples. A microplate reader (Syngery H1; BioTek) reading at
450nm analyzed colorimetric properties of each sample and sent data to a computer
running imaging software (Gen5 v2.06; BioTek). A standard curve was generated and
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raw colorimetric values fit to transform values to serum leptin concentration in picograms
per milliliter.
Carotid Body Type I Cell Calcium-Imaging
Carotid Body Type I cells were dissected from euthanized rats and dissociated as
previously described and their cellular hypoxic responses tested. A schematic of the
microscopy imaging setup used is shown in Figure 7. A ratiometric calcium-sensitive
fluorescent dye, FURA-2AM (Invitrogen) was used to visualize and quantify intracellular
calcium (Grynkiewicz et al., 1985). Type I cells were loaded with 5µM of FURA-2AM in
3mL of an extracellular HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid)
buffered salt solution (in mM): 10 HEPES, 11 glucose, 140 NaCl, 4.5 KCl, 2.5 CaCl2, 1
MgCl2 adjusted to pH 7.57 with NaOH at room temperature for a final pH of 7.4 at 37◦C.
Cells were loaded in the FURA-2AM containing HEPEs solution for 30 minutes before
being washed for 20 minutes in HEPES solution free of FURA-2AM to allow
intracellular esterases to cleave the acetoxy-methyl-ester (AM) group, thus activating the
dye. Coverslips containing loaded cells were then placed in a recording chamber (RC25F; Warner Instruments) with gravity-fed solutions, pre-heated with an inline heater
(SH-27F; Warner Instruments) and maintained at 36◦C±1◦C via thermistor controlled
feedback (TC-344B; Warner Instruments), being removed at 8mL per minute via a
peristaltic pump (RP-1; Rainin-Dynamax). Cells were visualized using an inverted
microscope (TE2000-U; Nikon) with a 40x oil immersion objective lens (S Fluor; Nikon)
with image acquisition controlled by MetaFluor software (v7.1.2; Molecular Devices).
Cells loaded with FURA-2 were excited every 5 seconds with a 50msec exposure to
340nm and 380nm light generated by passing white light, generated from a 175W xenon
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arc lamp (Lambda-LS; Sutter), through a filter wheel (Lambda 10-3; Sutter) containing
340nm and 380nm light filters (Chroma). To prevent photodamage of cells, neutral
density filters (0.7 optical density; Chroma) were placed in the light path before cellular
exposure. Filtered light was then passed to the cells via a dichroic mirror beamsplitter
(400 DCLP; Chroma) where light above 400nm was transmitted and light below 400nm
was reflected. Light emitted, generated from the excitation of FURA-2, above 400nm,
was transmitted through the dichroic mirror beamsplitter, then through an emitter filter
(D510/80; Chroma), and finally recorded using a Coolsnap HQ2 charge-couple device
camera (Photometrics). In image acquisition software, regions of interest were manually
selected and emission values at 510nm during excitation at 340nm and 380nm were
logged along with ratiometric values (340nm/380nm). Once a Carotid Body Type I cell
was located, the experiment was started and image acquisition began with a baseline
recording. Next, to test cell viability and excitability, gravity-fed into the recording
chamber was a high-potassium (35mM K+) solution (in mM): 10 HEPES, 11 glucose,
64.5 NaCl, 80 KCl, 2.5 CaCl2, 1 MgCl2 adjusted to a pH of 7.57 with KOH at room
temperature for a pH of 7.4 at 37◦C. The high-potassium solution was applied for 15
seconds or until cellular depolarization was achieved, after which the physiological
HEPES buffered salt solution (bubbled with 10% O2, 5% CO2, balanced N2) was
reapplied. Five minutes after repolarization of the cell, a hypoxic HEPES buffered salt
solution (5% CO2, 95% N2; bath O2: < 10 torr) was administered to the cells for 90
seconds. After 90 seconds the physiological HEPES buffered salt solution was reapplied,
five minutes were then allowed to elapse after cellular repolarization, followed by a final
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35mM high-potassium solution to ensure cell viability was maintained throughout the
experiment.
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Figure 7: Schematic (adapted from Pye, 2015) depicting cellular calcium imaging
experimental setup
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Results
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Diet Effects on Physiology
Weight
Thirty-six male Sprague-Dawley rats, separated into two equal groups (n=18),
were fed either a high fat or control chow for 16 weeks. After two weeks on a high-fat
chow diet, the HFF group weighed significantly more than the control group (p<.01;
313.6 g ± 4.029 g vs. 295.1 g ± 3.208 g). After the fifth week of diet, HFF group weights
were increasingly significantly different (p<.001; 375.2 g ± 7.641 g vs. 342.2 g ± 4.481
g). Weights continued to be significantly higher in HFF animals through the 16th week of
feeding (p<.0001; 505.8 g ± 13.86 g vs. 436.4 g ± 6.997 g), data shown in Figure 1; the
CF group also weighed significantly less at the day of sacrifice (at the end of the 16th
week of feeding) compared to the HFF group (p<.001; 444.1 g ± 7.090 g vs. 512.6 g ±
14.70 g), data shown in Figure 8 and Figure 9.
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Figure 8. Effects of 16 weeks of high fat or control feeding on weekly weight gain.
Weekly weighing showed high fat fed (HFF; n=18) animals to be significantly heavier
than controls (n=18) after two weeks of feeding (p<.05).
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Figure 9. Effect of 16 weeks of high fat or control feeding on weight gain. After 16
weeks on diet, final averaged group weights showed control fed (CF; n=18) animals
weighing significantly less than HFF (n=18) animals (p<.001; 444.1 g ± 7.09 g vs. 512.6
g ± 14.7 g).
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Metabolism
Indirect calorimetry was used to measure the resting metabolism of HFF or CF
animals. A respiratory exchange ratio (RER) was calculated for each animal by dividing
CO2-produced min-1 kg-1 by O2-consumed min-1 kg-1 (RER: VCO2/VO2), after adjusted
for standard temperature, pressure, and partial pressure of water vapor subtracted. After
16 weeks on the diet regimen CF animals had a significantly higher resting metabolism
compared to HFF animals (p<.01; 0.8839 RER ± 0.0371 RER vs. 0.7679 RER ± 0.01769
RER) shown in Figure 10, which was a function of lower CO2-production in HFF
animals (p<.0001; 10.02 mL ± 0.1609 mL CO2 min-1 kg-1 vs. 12.15 mL ± 0.418 mL CO2
min-1 kg-1).
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Figure 10. Effect of 16 weeks of high fat or control feeding on resting respiratory
exchange ratio (RER: VCO2/VO2 kg-1). CF animals (n=18) had a significantly higher
RER compared to HFF group (n=18) (p<.01; 0.8839 ± 0.0371 RER vs. 0.7679 ± 0.01769
RER), a function lower CO2 production in HFF animals (p<.0001; 10.02 ± 0.1609 mL
CO2 min-1 kg-1 vs. 12.15 ± 0.418 mL CO2 min-1 kg-1).
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Serum Leptin
After the 16th week on the diet regimen, non-fasted animals were sacrificed, blood
collected and processed, and serum frozen before being used for quantification of
endogenous leptin levels via ELISA. Standards ran in duplicate were significantly
correlated (p<.05 r2: 0.997). Sixteen weeks of HFF resulted in significantly lower serum
leptin levels in CF animals compared to HFF animals (p<.0001; 1.29 ng/mL ± 0.12
ng/mL vs. 3.05 ng/mL ± 0.24 ng/mL), shown in Figure 11. There was also a significant
positive correlation between animals’ weight and serum leptin levels (n=36; p<.0001; r2:
0.372), shown in Figure 12.
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Figure 11. Serum leptin concentrations resulting from 16 weeks of high fat (n=18) or
control feeding (n=18). Serum leptin concentrations were significantly lower in CF
animals compared to those HFF (p<.0001; 1.29 ± 0.12 ng/mL vs. 3.05 ± 0.24 ng/mL).
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Figure 12. There was a significant positive correlation between animals’ weight and
serum leptin levels at time of sacrifice (n=36; p<.0001; r2=0.372).
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Heart Weights
Immediately after sacrifice, the hearts of each animal were resected, excess tissue
removed, and a “wet” weight taken. Hearts were then dried for 24 hours at 75◦C before a
“dry” weight taken. The “dry” and “wet” weights were averaged for each heart and this
value used for analysis, data shown in Figure 13. After 16 weeks on diet, CF animals
(n=18) had significantly lower heart weights compared to HFF animals (n=18; p<.01;
1.901 g ± 0.056 g vs. 2.207 g ± 0.114 g).
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Figure 13. CF animals (n=18) had significantly lower heart weights compared to HFF
animals (n=18; p<.01; 1.901 ± 0.056g vs. 2.207 ± 0.114g).
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Lung Weights
Immediately after sacrifice, the lungs of each animal were resected, excess tissue
removed, and a “wet” weight taken. Lungs were then dried for 24 hours at 75◦C before a
“dry” weight was taken. The “dry” and “wet” weights were averaged for each organ and
this value used for analysis, data shown in Figure 14. After 16 weeks on diet, CF animals
(n=18) had significantly lower lung weights compared to HFF animals (n=18; p<.01;
1.518 ± 0.031g vs. 1.733 ± 0.062g).
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Figure 14. CF animals (n=18) had significantly lower lung weights compared to HFF
animals (n=18; p<.01; 1.518 ± 0.031g vs. 1.733 ± 0.062g)
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Whole-Body Plethysmography
Assessment of Respiratory Parameters
Whole-body plethysmography (experimental traces shown in Figures 15 & 16)
tested the acute hypoxic response of animals fed either a high-fat or ingredient-matched
control chow. Sixteen weeks of high fat feeding altered resting baseline minute
ventilation (VE: mL min-1 kg-1; the product of breathing frequency (FR: breath min-1) and
tidal volume (TV: mL breath-1)) and VE during the first-phase of the hypoxic response
(seventy-second bin: seconds twenty through ninety during hypoxic exposure), but not
during the second-phase (two-minute bin: minutes’ four through five during hypoxic
exposure), shown in Figure 17. CF animals (n=18) had a significantly increased baseline
minute ventilation (VE: mL min-1 kg-1) compared to HFF animals (n=18; p<.01; 442.8 ±
15.29 mL min-1 kg-1 vs. 373.9 ± 13.46 mL min-1 kg-1). CF also had a significantly
increased VE during the immediate onset of hypoxia (<90 seconds) compared to HFF
animals (p<.01; 1298.2 ± 52.61 mL min-1 kg-1 vs. 1084.1 ± 46.25 mL min-1 kg-1). There
was no significant difference in the VE for the second-phase (3-5 minutes) of the hypoxic
response between CF and HFF animals (1168.9 ± 59.81 mL min-1 kg-1 vs. 1067.5 ± 53.16
mL min-1 kg-1).
Sixteen weeks of high fat feeding resulted in no significant differences in FR
between the groups during any of the conditions. No significant difference were noted
between CF (n=18) and HFF (n=18) animals FR during baseline (57.37 ± 2.581 breath
min-1 vs. 61.99 ± 2.817 breath min-1), the first-phase of the hypoxic response (149.2 ±
7.447 breath min-1 vs. 151.4 ± 5.75 breath min-1), nor the second-phase of the hypoxic
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response (139.8 ± 7.817 breath min-1 vs. 153.1 ± 8.529 breath min-1), shown in Figure
18.
Differences in VE between the groups can be attributed to decreased TV of the
HFF animals. CF animals (n=18) had a significantly increased TV during baseline
compared to HFF animals (n=18; p<.0001; 8.163 ± 0.263 mL breath-1 kg-1 vs. 6.412 ±
0.212 mL breath-1 kg-1). CF animals also had a significantly increased TV during both the
first-phase (p<.0001; 10.63 ± 0.354 mL breath-1 kg-1 vs. 8.587 ± 0.287 mL breath-1 kg-1)
and second-phase (p<.001; 9.693 ± 0.277 mL breath-1 kg-1 vs. 8.132 ± 0.269 mL breath-1
kg-1) compared to HFF animals, shown in Figure 19.
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Figure 15. Experimental whole-body plethysmography minute ventilation trace example.
Red box shows a two-minute data bin used to analyze resting baseline minute ventilation
in normoxic conditions. A baseline was defined as the most quiescent period of breathing
before a hypoxic exposure. Blue rectangular box shows a 70-second data bin used to
analyze the first phase of the biphasic hypoxic response. Green rectangular box shows a
two-minute data bin used to analyze the second phase of the biphasic hypoxic response.
Two-second averages are visualized as individual data points.
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Figure 16. Control whole-body plethysmography minute ventilation trace example. Red
box shows a two-minute data bin used to analyze resting baseline minute ventilation in
normoxic conditions. A baseline was defined as the most quiescent period of breathing
before a hypoxic exposure. Blue rectangular box shows a 70-second data bin used to
analyze the first phase of the biphasic hypoxic response. Green rectangular box shows a
two-minute data bin used to analyze the second phase of the biphasic hypoxic response.
Two-second averages are visualized as individual data points.
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Figure 17. Sixteen weeks of high fat feeding altered resting baseline minute
ventilation (VE: mL min-1 kg-1; the product of breathing frequency (breath min-1)
and tidal volume (mL breath-1)) and VE during the first-phase of the hypoxic
response (seventy-second bin: seconds twenty through ninety during hypoxic
exposure), but not during the second-phase (two-minute bin: minutes’ four through
five during hypoxic exposure). CF animals (n=18) had a significantly increased baseline
minute ventilation (VE: mL min-1 kg-1) compared to HFF animals (n=18; p<.01; 442.8 ±
15.29 mL min-1 kg-1 vs. 373.9 ± 13.46 mL min-1 kg-1). CF also had a significantly
increased VE during the immediate onset of hypoxia compared to HFF animals (p<.01;
1298.2 ± 52.61 mL min-1 kg-1 vs. 1084.1 ± 46.25 mL min-1 kg-1). There was no
significant difference in the VE between CF and HFF animals during the second-phase of
the hypoxic response (1168.9 ± 59.81 mL min-1 kg-1 vs. 1067.5 ± 53.16 mL min-1 kg-1).
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Figure 18. Sixteen weeks of high fat feeding resulted in no significant differences in
breathing frequency (breath min-1) between the groups during any of the conditions.
No significant difference were noted between CF (n=18) and HFF (n=18) animals
breathing frequency during baseline (57.37 ± 2.581 breath min-1 vs. 61.99 ± 2.817 breath
min-1), the first-phase of the hypoxic response (149.2 ± 7.447 breath min-1 vs. 151.4 ±
5.75 breath min-1), nor the second-phase of the hypoxic response (139.8 ± 7.817 breath
min-1 vs. 153.1 ± 8.529 breath min-1).
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Figure 19. Sixteen weeks of high fat feeding significantly reduced HFF animals’
tidal volume in all conditions compared to CF animals. CF animals (n=18) had a
significantly increased tidal volume during baseline compared to HFF animals (n=18;
p<.0001; 8.163 ± 0.263 mL breath-1 kg-1 vs. 6.412 ± 0.212 mL breath-1 kg-1). CF animals
also had a significantly increased tidal volume during both the first-phase (p<.0001;
10.63 ± 0.354 mL breath-1 kg-1 vs. 8.587 ± 0.287 mL breath-1 kg-1) and second-phase
(p<.001; 9.693 ± 0.277 mL breath-1 kg-1 vs. 8.132 ± 0.269 mL breath-1 kg-1) compared to
HFF animals.
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Assessment of the Hypoxic Response
The acute biphasic hypoxic response of all animals (n=36) was tested via
exposure to a 10% O2, balanced N2 air mixture for five minutes. The absolute change in
minute ventilation (ΔVE) during the first-phase of the biphasic hypoxic response was
analyzed by calculating the absolute value (VE during first-phase of hypoxia minus the
VE during baseline) of the hypoxic response (first 70 seconds of exposure). The ΔVE
during the second-phase of the biphasic hypoxic response was analyzed by again
calculating the absolute value (VE during the first-phase of hypoxia minus the VE during
baseline) of the hypoxic response.
The carotid body mediated, first-phase of the biphasic hypoxic response
(Cummings & Wilson, 2005; Pedersen, Fatemian, & Robbins, 1999; Powell, Milsom, &
Mitchell, 1998) was similar for CF (n=18) versus HFF (n=18) animals (1102 ± 83.75 mL
min-1 kg-1 vs. 937.1 ± 63.45 mL min-1 kg-1), shown in Figure 20. However, the secondphase of the biphasic hypoxic response was significantly different between groups,
shown in Figure 21. CF (n=18) animals had an increased ΔVE from baseline to the
second-phase of the hypoxic response compared to HFF (n=18) animals (p<.05; 855.4 ±
44.05 mL min-1 kg-1 vs. 710.1 ± 41.89 mL min-1 kg-1).
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Figure 20. Sixteen weeks of high fat feeding did not significantly alter the first-phase
of the hypoxic response (ΔVE from baseline to first-phase of hypoxic response)
between groups. The first-phase of the hypoxic response (ΔVE) was not significantly
different between CF (n=18) and HFF (n=18) groups (1102 ± 83.75 mL min-1 kg-1 vs.
937.1 ± 63.45 mL min-1 kg-1).
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Figure 21. Sixteen weeks of high fat feeding significantly altered the second-phase of
the hypoxic response (ΔVE from baseline to second-phase of hypoxic response)
between the groups. CF animals (n=18) had an increased absolute change in minute
ventilation (ΔVE) from baseline to the second-phase of the hypoxic response compared to
HFF animals (n=18; p<.05; 855.4 ± 44.05 mL min-1 kg-1 vs. 710.1 ± 41.89 mL min-1 kg).
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Calcium-Imaging
The hypoxic response of freshly dissected and isolated carotid body Type I cells
was studied by measuring the changing intracellular calcium concentrations in response
to application of a low-oxygen (bath O2 = 10 Torr) stimulus (Dunn, 2015). A high
potassium stimulus (35mM K+ HEPES-buffered extracellular solution) was used to
depolarize cells, evoking a rise in intracellular calcium via influx of calcium through
voltage-gated calcium ion channels (Buckler, 2007). Only cells responding to this
stimulus were used for experimentation; non-responsive cells were assumed to either be
non-viable or not cells of interest (e.g., carotid body Type I cells). The initial peak in
Figure 22 shows this cellular response to a high potassium HEPES-buffered solution.
After return to baseline, cells were exposed to a low-oxygen stimulus for 90-seconds:
responses are shown in the blue box in Figures 22 & 23. Shown in Figure 24, the single
highest peak intracellular calcium level was calculated and values averaged for each
group. CF (n=16) and HFF (n=16) peak cellular responses during hypoxia were similar
(1.021 ± 0.022 F340/F380 vs. 1.038 ± 0.029 F340/F380). Shown in Figure 25, cellular
responses during hypoxia were analyzed. A seventy-second data bin (seconds 20 through
90) was used to average cellular responses during a 90-second hypoxic exposure. Again,
no differences were noted in intracellular calcium levels between groups during the
hypoxic exposure (0.8788 ± 0.0353 F340/F380 vs. 0.9196 ± 0.0316 F340/F380).
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Figure 22. Representative trace of the effect of hypoxia (blue box; bath O2= 10 Torr) on
isolated Carotid Body (CB) Type I cells. Intracellular calcium of CB Type I cells was
fluorescently labeled, visualized, and quantified using FURA-2 during hypoxic exposure
(bath O2 =10 Torr) by exciting the dye with 340nm/380nm light and emission recorded at
510nm. Blue box represents a 70-second data bin (during a 90-second hypoxic exposure)
used for statistical analysis.
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Figure 23. Representative trace of the effect of hypoxia (blue box; bath O2= 10 Torr) on
isolated Carotid Body (CB) Type I cells. Intracellular calcium of CB Type I cells was
fluorescently labeled, visualized, and quantified using FURA-2 during hypoxic exposure
(bath O2 =10 Torr) by exciting the dye with 340nm/380nm light and emission recorded at
510nm. Blue box represents a 70-second data bin (during a 90-second hypoxic exposure)
used for statistical analysis.
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Figure 24. Diet did not significantly alter the peak cellular response of isolated CB
Type I cells during hypoxic exposure between CF (n=16) and HFF (n=16) groups.
The single highest peak cellular response during hypoxic exposure was analyzed.
Insignificant differences suggest calcium handling was not altered during hypoxic
exposure. (1.021 ± 0.022 F340/F380 vs. 1.038 ± 0.029 F340/F380)
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Figure 25. Diet did not significantly alter the averaged cellular hypoxic response of
isolated CB Type I cells. A seventy-second data bin averaged cellular responses during a
90-second hypoxic exposure. Comparable responses suggest differences in breathing are
not due to CB Type I cell changes. (0.8788 ± 0.0353 F340/F380 vs. 0.9196 ± 0.0316
F340/F380)
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Statistics
Data are presented and visualized as mean ± standard error of the mean; values
were also weight adjusted per kilogram as noted. Data were statistically analyzed using
an unpaired Student’s t-test; significance was indicated by values of p<.05. In figures,
one star denoted significance of p<.05, two stars denoted significance of p<.01, three
stars denoted significance of p<.001, four stars denoted significance of p<.0001.
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Discussion
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Summary of Results
These experiments demonstrated that high fat feeding in rats leads to significant
physiological changes including weight gain, hyperleptinemia, lowered metabolism
(RER), and depression of breathing during baseline and hypoxic exposure. Although
respiratory depression is evident, the mechanism underpinning this attenuation does not
appear to be mediated by the carotid body type I cell. Similar hypoxic responses (ΔVE)
between groups provide further evidence for lack of involvement of the carotid bodies in
the development of respiratory depression.
High fat feeding of rats produced a model of obesity very similar to that seen in
man. For example, HFF animals, on average, gained significantly more weight compared
to CF animals and were considered obese for their weight range (Schemmel, Mickelsen,
& Gill, 1970; Novelli et al., 2007). Reduced metabolism (RER: VCO2/VO2 kg-1) is also
noted in both our diet-induced obese (DIO) rat model and obese humans (McLean &
Tobin, 1987; Miller et al., 2012; Goodpaster, Wolfe, & Kelley, 2002; Martin et al., 2006).
Our HFF animals were observed to have a resting RER near 0.76. This reduction was a
function of lower CO2 production; O2-consumption was similar among groups. A low
RER, near 0.70, is indicative of increased fatty acid oxidation, while an RER closer to 1.0
is indicative of utilization of carbohydrates for energy (Peronnet & Massicotte, 1991;
McLean & Tobin, 1987; Martin et al., 2006). For example, oxidation of a carbohydrate
molecule yields six molecules of CO2 after consumption of six molecules of O2,
producing 38 molecules of ATP in the process (6 CO2/6 O2 = 1.0 RER). Oxidation of a
molecule of fatty acid yields 16 molecules of CO2 after consumption of 23 molecules of
O2, producing a staggering 129 molecules of ATP in the process (16 CO2/23 O2 = 0.7
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RER) (Peronnet & Massicotte, 1991). Our results show that, via high fat feeding, HFF
rats shifted their substrate utilization to fatty acid oxidation, subsequently lowering their
RER. In 2006, Martin and colleagues showed that administration of exogenous leptin to
rats significantly reduced their RER. As our rats were hyperleptinemic and fed a high fat
diet, these dueling depressors of metabolism may fully explain our HFF rats’ reduction in
RER. Accompanying a reduction in RER, significant depression of breathing was
observed in our HFF animal model, a phenomenon also noted to occur in obese humans
(Piper & Grunstein, 2011; Miller et al., 2012).
Post-mortem hearts were resected from our animals, non-cardiac tissue and blood
removed, and wet and dry organ weights averaged (Frappell & Mortola, 1994).
Compared to CF animals, HFF animals had significantly heavier hearts. As the heart is a
muscle, increased mass correlates with increased cardiac load (e.g., hypertension) and is
suggestive of cardiac hypertrophy (Frappel & Mortola, 1994; Okubo & Mortola, 1988;
Cunningham, Brody, & Jain, 1974). Similar to our HFF rat model, obese humans suffer
from cardiac hypertrophy (i.e., enlarged heart) typically from hypertension resulting from
diet (i.e., high salt or fat intake), breathing pathologies (e.g., sleep apnea, COPD), and/or
greater body mass (i.e., obesity) necessitating an augmented cardiac output (Noda et al.,
1995; Alexander, 1964; Sica et al., 2000).
Post-mortem lungs were resected from our animals, non-pulmonary tissue and
blood removed, and wet and dry organ weights averaged (Frappell & Mortola, 1994).
Compared to CF animals, HFF animals had significantly heavier lungs. Inselman and
colleagues (1988) observed that rats fed a high fat diet had significantly increased lung
surface area, total volume, and alveolar enlargement due to “obesity-induced hyperplastic
63

lung growth”. Increases in lung morphological measurements correlate with increases in
lung mass and could explain the increased weight of our HFF animals’ lungs (Inselman et
al., 1988). In high fat fed rats, obesity led to diminished lung compliance, increased
deposition of lipids within the lungs, and elevated surfactant production (Inselman,
Chander, & Spitzer, 2004). In our HFF animals, decreased tidal volume indirectly
provides evidence for diminished lung compliance (Ehrner, 1960; Salome, King, &
Berend, 2010). Provided via a high-fat chow, high concentrations of circulating lipids,
such as those found in the obese man, provide the necessary substrate for lung surfactant
production. Lung surfactant, produced by type II alveolar cells, coats the alveolar surface
at the “air/water interface” and lowers surface tension to prevent alveoli collapse, thus
increasing/maintaining lung compliance (Goerke, 1974). The adipokine leptin, found in
high circulating levels in obese humans and in our HFF animals, interacts and binds with
leptin receptors on type II alveolar cells, and increases surfactant production (Torday &
Rehan, 2006; Bergen et al., 2002). Increased surfactant production may be protective by
helping overcome the diminished lung compliance noted in obese individuals, such as
through increasing alveolar surface area despite lowered tidal volume (Inselman,
Chander, & Spitzer, 2004). Protein analysis (i.e., chromatography, western blot)
quantifying the main surfactant constituent, dipalmitoylphosphatidylcholine, could have
revealed if our HFF animals had increased lung surfactant production (Goerke, 1974).
Despite lowered tidal volume among HFF animals, VO2 (oxygen consumption) was
similar between groups, thus suggesting a compensatory mechanism allowed animals to
maintain proper ventilation in the face of decreased tidal volume. As stated above,
compensatory mechanisms could include increasing lung surface area, which is
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evidenced from increased lung mass, and potential increases in lung surfactant
production.
Leptin levels were similarly increased in our rodent model as they are in the obese
man (Caprio et al., 1996; Lee et al., 2001). A weak, but positive correlation between body
mass and leptin was noted (r2=0.372) in our animals. Previously, it has been shown that
exogenous administration of the adipokine leptin may lead to increases in respiration
(Olea et al., 2015; Pye et al., 2015; Pye et al., 2016). In obese, leptin-deficient mice,
peripheral infusion of exogenous leptin led to a profound increase in breathing
(O’Donnell et al., 1999; O’Donnell et al., 2000). However, in obese humans, respiratory
depression persists despite high circulating levels of this respiratory stimulant, leptin
(Phipps et al., 2002; Yee et al., 2006). Similar to the theory of insulin resistance leading
to diabetes, a theory of leptin resistance may explain the hypoventilation that
accompanies obesity, despite chronic hyperleptinemia (Burguera et al., 2000; Myers,
Cowley, & Unzberg, 2008), such as seen in our animal model.
Leptin resistance is preceded by hyperleptinemia induced from a diet typically
high in fat (Knight et al., 2010). First, consumption of high fat foods leads to obesity with
a subsequent rise in serum leptin levels; adipocytes continually synthesize and secrete
leptin along a constitutive secretory pathway (Cammisotto et al., 2006; Bradley et al.,
2000). Development of hyperleptinemia leads to “chronic overstimulation of the leptin
receptor and activation of negative feedback pathways that block further leptin signaling”
(Knight et al., 2010). Leptin receptor (Ob-Rb; JAK-STAT mediated) activation leads to
downstream upregulation of suppressor of cytokine signaling 3 (SOCS-3), a protein that
attenuates leptin signaling (i.e., blocking STAT protein phosphotyrosine binding sites on
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receptor) (Howard et al., 2004; Bjørbaek et al., 1998; Friedman & Halaas, 1998; Knight
et al., 2010). A simplified schematic of this theorized process is shown in Figure 26. In
SOCS-3 knock-out mice, leptin signaling was potentiated, providing further evidence for
the role SOCS-3 plays in attenuating leptin signaling (Howard et al., 2004). Thus,
chronically elevated leptin levels, such as those observed in obese individuals and this
animal model, may lead to leptin insensitivity due to downregulation of leptin receptors
and suppression of leptin receptor activity (Bjørbaek et al., 1998; Knight et al., 2010;
Friedman & Halaas; 1998).
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Figure 26. Schematic showing the theorized process by which leptin resistance
occurs at the level of the carotid body type I cell. Briefly, chronic overstimulation of the
leptin receptor (LepRb) due to hyperleptinemia causes upregulation of SOCS-3, a protein
that attenuates leptin signaling by blocking phosphotyrosine binding sites (e.g., 985Y) on
the intracellular receptor surface. Schematic adapted from Israel & Chua (2010).
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Capable of crossing the BBB, leptin exerts is satiating effects within the
hypothalamus (Burguera et al., 2000). Chronic overstimulation of leptin receptors here
leads to an attenuation of leptin signaling (Howard et al., 2004; Knight et al., 2010). In
obese individuals, the diminished ability for leptin to signal satiation exacerbates obesity
through an inability to maintain negative feedback, thus leading to marked hyperphagia
and subsequent weight gain (Myers, Cowley, & Münzberg, 2008), as was seen in our
animal model. Peripherally, long and short forms of leptin receptors (Ob-Rf>Ob-Rc>ObRa>Ob-Rb) are located on type I cells of both the rat and human carotid body (Porzionato
et al., 2011). It previously has been demonstrated that application of obese levels of
exogenous leptin to ex-vivo, intact, and arterially perfused carotid bodies increased their
baseline firing rates and sensory responses to hypoxia (Pye et al., 2016). These effects are
believed to be isolated to leptin’s effects on carotid body type I cells as the glial-like and
supportive type II cells are not electrically excitable, nor express functional leptin
receptors (Porzionato et al., 2011). In 2015, Pye and colleagues demonstrated that acute
application of leptin to isolated carotid body type I cells, in obese levels, was shown to
increase intracellular calcium levels and peak membrane currents. Membrane
depolarization of type I cells activates voltage-gated calcium channels leading to
subsequent neurotransmitter (NT) release, thus suggesting leptin may have modulatory
effects on NT release from type I cells (Buckler & Vaughan-Jones, 1994).
To investigate whether high-fat feeding changes oxygen sensitivity of isolated CB
type I cells, we fluorescently labeled and imaged intracellular calcium levels during
baseline and hypoxic exposure (bath O2: < 10 torr). CB type I intracellular calcium levels
rise during exposure to hypoxia leading to subsequent NT release onto postsynaptic
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neuronal connections (Buckler & Vaughan-Jones, 1994). Between our HFF and CF
groups, we observed no differences in carotid body type I cell intracellular calcium levels
at rest nor during the low-oxygen stimulus. Differences in intracellular calcium-handling
would have alluded to potential changes in oxygen-sensitivity and dissimilarity of
cellular NT release compared to CF (Buckler & Vaughan-Jones, 1994). Despite our HFF
animals having significantly higher leptin levels than controls, circulating HFF animal
serum leptin levels, on average, were more than sixty-five times lower than the
exogenous concentrations used by Pye et al. (2015) to elicit type I cell responses (i.e.,
200 ng/mL vs. 3.05 ng/mL). These results suggest that our animals’ serum leptin levels
may have not been raised high enough to cause an effect on calcium-handling by the
isolated CB type I cell. Despite no differences at the level of the isolated carotid body
type I cell, breathing differences were noted between our groups of animals.
Whole-body plethysmography was used to measure respiratory parameters at rest
and during exposure to hypoxia (10% O2). To prevent the depletion and build-up of
oxygen and carbon dioxide, respectively, a constant, humidified gas flow (2.5 L/min)
passed through the chamber while differential pressure sensors recorded perturbations in
chamber pressures (box flow: mL/sec) produced by the breathing movements of the
animal. For example, during inspiration box flow was decreased and during expiration
box flow increased. Computer software (DSI FinePointe v2.3.1.16) automatically
extrapolated breathing frequency (breath/min), tidal volume (mL/breath), and the product
of these two variables, minute ventilation (mL/breath/min) from the raw waveform
digitized by an amplifier (Buxco QT Digital Preamplifier). After allowing the animal a
set amount of time to acclimate to the chamber, breathing parameters at rest were
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measured before exposure to a hypoxic stimulus. Across all conditions (rest, 1st, and 2nd
phase of the biphasic hypoxic response), breathing frequency was similar between the
animal groups. Tidal volume, however, was significantly depressed across all conditions
for the HFF animals. One explanation for the decreased tidal volume is fat deposition
around and in the chest cavity which was noted during post-mortem lung resection,
despite no quantification being made. Fat tissue deposited in and around the chest
restricts lung expansion, increases the work load on respiratory muscles (e.g., intercostal),
and subsequently decreases chest wall compliance, all potentially leading to decreased
tidal volume (Luce, 1980; Salome, King, & Berend, 2010). For example, increased
abdominal adiposity restricts downward movement of the diaphragm, thus leading to
decreased total lung capacity and tidal volume (Salome, King, & Berend, 2010). Direct
measures of abdominal adiposity were not made with our animals but could have been
made by simply taking the animal’s abdominal circumference (Salome, King, & Berend,
2010; Novelli et al., 2007).
Despite depressed breathing during rest and hypoxic exposure, oxygen sensitivity
seemingly remained unchanged in the HFF animals. The change in breathing from rest to
hypoxic exposure (ΔVE), or the hypoxic ventilatory response (HVR), was similar for both
groups from rest to the carotid body mediated, 1st-phase of the biphasic HVR (first 70
seconds of exposure). Time-matching this breathing data to the isolated CB Type I cell
calcium-imaging data, we also see no differences in CB sensory responses to hypoxia.
This evidence further supports our data interpretation of oxygen sensitivity remaining
unchanged, at least at the level of the CB and whole-animal. However, there were
differences between groups for the change in breathing occurring from rest to the 2nd-
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phase of the biphasic HVR (ΔVE; minutes 3-5: two-minute data bin). Breathing during
this phase is determined less from carotid body input (as is the 1st-phase; due to sensory
hypoxic decline of the CB) and instead encompasses input from a spectrum of sensory
modalities (i.e., aortic bodies, NTS, RTN) (Cummings & Wilson, 2005; Pedersen,
Fatemian, & Robbins, 1999). Several mechanisms may explain the depression in
breathing occurring during this phase. First, CB activity diminishes over the course of
minutes due to sensory hypoxic decline (Cummings & Wilson, 2005). As CB input to the
respiratory centers in the brainstem diminishes, minute ventilation decreases as well
(Frappell, Lanthier, Baudinette, & Mortola, 1992). Unfortunately, our cellular recordings
only analyzed an acute, 70-second hypoxic exposure; longer recordings (> 5 min) would
have provided evidence of sensory hypoxic decline of our CB type I cells. However,
Pandit, Collyer, & Buckler (2010) conducted these longer type I cellular recordings and
provided evidence that the CB sensory decline is due to diminutions in intracellular
calcium levels in CB type I cells. For example, after two minutes of hypoxic exposure,
intracellular calcium levels decreased significantly compared to levels during immediate
hypoxic exposure (< 90 seconds). However, the authors are quick to point out that
intracellular calcium levels, although an indirect measure of NT release from CB type I
cells, may not linearly correlate with the activity of the CSN. However, the responses of
the CB to hypoxia similarly resemble the HVR noted at the level of the whole animal and
human. For example, as CB activity declines, minute ventilation declines as well; at the
level of the whole-animal, this phenomenon manifests itself as the sharp increase in
breathing (1st-phase) followed by a decrease over the course of minutes (2nd-phase)
(Pandit, Collyer, & Buckler, 2010; Cummings & Wilson, 2005; Frappell, Lanthier,
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Baudinette, & Mortola, 1992). Although our cellular experiments only analyzed a 90second hypoxic exposure, a longer 5-minute exposure would have provided evidence as
to if the depression during the 2nd-phase of the HVR is due to CB sensory hypoxic
decline.
A second explanation for the different 2nd-phase includes that the hypoxic
stimulus was provided with no accompanying CO2; as the animals hyperventilated due to
the hypoxic conditions, it is possible that they upset their acid-base balance by blowing
off excessive amounts of CO2 (e.g., hyperventilation induced hypocapnia; respiratory
alkalosis). There was a notable decrease in VE from the 1st-phase to the 2nd-phase. This
potentially may be due to the respiratory alkalosis induced from hyperventilation due to
hypoxia. As CO2 is a strong respiratory stimulant, its diminution in the blood due to
hyperventilation leads to increases in pH, decreases in PCO2, and decreases in minute
ventilation (Somers et al., 1989). For example, when Somers and colleagues (1989) had
individuals breath a hypoxic gas mixture, observers noted increased breathing during
isocapnic-hypoxia exposure (i.e., PCO2 levels maintained at equilibrium despite
hyperventilation) compared to lowered breathing hypocapnic-hypoxia (i.e., no
maintenance of PCO2 during hypoxic exposure) exposure.
A third explanation for the reduced change in breathing from rest to the 2nd-phase
of the biphasic HVR, in HFF animals, could be due to hypoxia-induced hypometabolism.
Unfortunately, no metabolic measurements were made during hypoxic exposure for our
rats due to methodological limitations in our system setup. However, results provided by
Frappell and Mortola (1994) show that, in rats subjected to either acute or chronic
hypoxia, significant reductions in metabolism (i.e., VO2) concurrently occur. In the face
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of hypoxia mammals have two main coping strategies at their disposal: increasing minute
ventilation or decreasing metabolism (Frappell et al., 1992). Evidence from Frappell’s
group (1992; 1994) shows that rats cope with hypoxia in a biphasic manner; large
increases in minute ventilation, mediated by the carotid bodies, precede the hypoxiainduced hypometabolic shift and slight reduction in minute ventilation that occurs during
the second-phase (occurring over minutes). A figure adapted from Powell, Milsom, &
Mitchell (1998) concurs with work done by Frappell’s group in demonstrating that the
mammalian hypoxic ventilatory response is biphasic (over the course of minutes), and
leads to hypoxic ventilatory decline.
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Figure 27. Schematic adapted from Powell, Milsom, & Mitchell (1998) showing the
time-course for development of, acutely, hypoxic ventilatory decline (HVD), ventilatory
acclimatization to hypoxia (VAH), and hypoxic desensitization. The line represents
arbitrary minute ventilation units (VE).

74

These data from our experiments suggest that high-fat feeding of rats leads to
respiratory depression during rest and exposure to hypoxia. However, this depression
does not appear to be due to leptin’s effects on the type I cells of the CB. Similar CB type
I intracellular calcium levels between groups suggests calcium handling remained
unchanged during hypoxic exposure. Pye and colleagues (2015) observed that obese
quantities of exogenous leptin increased intracellular calcium levels through modulation
of BKCa channels. It is possible that we did not increase endogenous leptin levels enough
in our animals to see this effect. For example, Pye and coworker’s (2015) concentrations
were more that 65-times greater than that measured in-vivo in our HFF animals. In
studies performed by Van Heek and colleagues (1997), leptin resistance occurred after
nearly 60 daily injections of 10 mg/kg of leptin. These quantities Van Heek used to elicit
leptin resistance are hundreds of times larger than those found circulating within our HFF
animals. Again, compared to the levels used in these previous studies, it is apparent that
we did not increase leptin levels enough to elicit similar effects as noted by these
investigators. Future studies could increase the length of time spent on the high-fat diet.
Our study concluded after 16 weeks but doubling or tripling that time spent on the diet
may yield increased leptin levels. Although we used ingredient-matched chows for our
study, supplementing the HFF animals with high-fat “treats” (i.e., cookies, cakes, chips)
in addition to their high-fat chow may have thwarted the plateauing of the evolution of
the HFF animals body weights and further increased serum leptin levels.
Despite oxygen-sensitivity remaining unchanged, both at the level of the CB type
I cell and whole-animal, breathing depression was evident. The reduction in minute
ventilation accompanying obesity is a well-documented phenomenon occurring both in
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humans and lower ordered mammals alike. Attributions to obesity-related diaphragmrestriction, reduced metabolism, and potentially increased lung-surface area and
surfactant production (Inselman et al., 1988) all may explain the depression in breathing
noted in the HFF animals. The potential also remains that oxygen-sensitivity changed
centrally. For example, functional leptin receptors are found in the nucleus tractus
solitarius, a well-studied respiratory center (Hayes et al., 2010). Application of leptin to
cells within the NTS causes a dose dependent increases in minute ventilation (Inyushkin,
Inyushkin, & Merkulova, 2007). As leptin’s actions in this area work to increase
breathing, the potential exists for leptin resistance to blunt the stimulatory effect leptin
has on breathing, potentially by downregulation of leptin receptors in the NTS. Future
experiments would include looking at not only peripheral chemoreception, but central
chemoreception as well in hyperleptinemic animals.
Conclusion
Obese humans suffer from respiratory depression and an attenuated hypoxic
ventilatory response. Previous work has suggested the adipokine leptin may influence
breathing via its stimulatory actions on carotid body type I cells. Through high-fat
feeding, animals gained significantly more weight, reduction in metabolism resulted,
serum leptin levels were increased over 2-fold that of controls, and HFF rats
demonstrated depressed breathing at rest and during hypoxic exposure. Despite the
differences in breathing, oxygen-sensitivity at the level of the CB type I cell and wholeanimal remained unchanged. This data suggests that, despite depression of breathing
being evident, it is not a result of changes at the level of the CB type I cell. The potential
exists oxygen-sensitivity was altered centrally, but this would have manifested itself in
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breathing differences at the level of the whole-animal. Future studies would aim to
increase HFF animals weights much more in hopes of further increasing serum leptin
levels. It may be that obesity and the subsequent breathing depression exist on a
continuum and as obesity increases, breathing depression becomes more pronounced due
to increased leptin resistance. These future studies are needed to help gain a better
understanding of leptin’s endogenous role as a modulator of breathing.
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